Choosing an IVF Clinic Abroad: What Actually Matters
Key Takeaways
Choosing an IVF or ICSI clinic abroad is safer when judged by verifiable criteria rather than price or reviews alone: embryology lab accreditation, how success rates are actually reported (per cycle versus cumulative), what the legal framework requires, and whether recommended add-ons are evidence-based. None of these criteria depend on which country you compare — they apply to any clinic, anywhere.
Key evidence: ESHRE revised guidelines for good practice in IVF laboratories (2015) ESHRE good practice recommendations on add-ons in reproductive medicine (2023)
On this page
- Why Price and Reviews Alone Aren’t Enough
- Is the Embryology Lab Actually Accredited?
- How Transparent Is the Success-Rate Reporting?
- What Does the Legal Framework Allow — and Require?
- What’s Actually Included in the Cost Estimate?
- How Many Days Should You Realistically Plan For?
- What Happens if the First Cycle Doesn’t Work?
- Clinical Note
- At a Glance: A Clinic-Evaluation Checklist
- Frequently Asked Questions
Many patients researching IVF or ICSI abroad start by comparing countries. That is the wrong first question. A well-run clinic and a poorly run one can exist in the same city, sometimes on the same street. The criteria below apply regardless of where you are considering treatment, and they are the same questions a careful patient should ask about a clinic close to home.
Why Price and Reviews Alone Aren’t Enough
Short answer: Price reflects what is included in a quote, not clinical quality, and online reviews are not a substitute for verifiable standards.
A lower quoted price can mean a leaner protocol that genuinely fits your case — or it can mean genetic testing, medication, and freezing show up on the bill later. A higher price does not guarantee a better laboratory, either. Reviews mostly tell you who bothered to write one, not whether the embryology lab actually follows a documented quality system. Here is what you can verify before you book a flight.
Is the Embryology Lab Actually Accredited?
Short answer: Ask whether the lab follows a documented quality-management system, not just whether it is “modern” or “state of the art.”
The embryology laboratory is where a meaningful share of the outcome is decided — fertilization method, incubation conditions, and how embryos are graded and selected for transfer. The European Society of Human Reproduction and Embryology (ESHRE) publishes detailed good-practice recommendations covering staffing, quality management, laboratory safety, identification and traceability of gametes and embryos, and the specific procedures performed in an IVF lab, from oocyte retrieval through cryopreservation (ESHRE, Revised Guidelines for Good Practice in IVF Laboratories, 2015).
A clinic that can answer specific questions — how identity-witnessing works, how incubators are monitored, what its embryo-grading system is — is telling you something more useful than a marketing phrase. A clinic that cannot, or redirects to a general statement about “modern equipment,” has given you an answer too.
How Transparent Is the Success-Rate Reporting?
Short answer: Ask whether a quoted success rate is per embryo transfer or cumulative across a full treatment plan — the two numbers are not comparable.
Success rates are one of the most misused numbers in fertility marketing — rarely by making them up outright, more often by framing them to look better than they are: a rate per embryo transfer, in a favorable age group, with no denominator stated. The global registry consortium ICMART has pushed the field toward standardized definitions, in particular reporting the cumulative live-birth rate per aspiration — combining the outcome of a fresh transfer with any subsequent frozen embryo transfers from the same egg-collection cycle — because that number reflects what a patient actually experiences across a treatment plan, not a single transfer in isolation (Chambers et al., ICMART World Report: ART 2014, published 2021).
A clinic willing to state, in writing, how a quoted percentage was calculated — cycle type, age bracket, per-transfer or cumulative — is giving you a number you can actually use.
What Does the Legal Framework Allow — and Require?
Short answer: Fertility law varies by country on marital status, gamete source, and third-party reproduction — confirm the framework in writing before you travel, not after.
Some countries permit donor eggs or sperm and gestational surrogacy; others restrict treatment to a couple’s own gametes, or require proof of marriage. These rules are not a reflection of clinical quality in either direction — they are local law, and they determine what is even possible for your specific situation. Ask the clinic to confirm, in writing, what applies to your case before you book travel, and verify independently through your destination country’s official health-regulation authority rather than relying on the clinic’s summary alone.
What’s Actually Included in the Cost Estimate?
Short answer: A meaningful cost estimate separates the base cycle from items that are frequently billed separately.
A base IVF or ICSI cycle typically covers monitoring visits, egg retrieval, fertilization, and embryo culture through to a fresh transfer. Stimulation medication (which varies by ovarian response), preimplantation genetic testing, embryo freezing and its annual storage, a frozen embryo transfer in a later cycle, and surgical sperm retrieval are commonly quoted — and billed — separately. A detailed breakdown of what typically sits inside versus outside a base quote is worth reviewing before comparing any two clinics’ prices directly, since an apparently cheaper quote may simply exclude more line items.
How Many Days Should You Realistically Plan For?
Short answer: A fresh cycle usually needs a longer stay than a frozen embryo transfer; ask for a specific day-by-day estimate for your protocol, not a generic range.
The monitoring visits, egg retrieval, and fresh transfer typically require the longest single stay; a later frozen transfer is usually shorter. A step-by-step walkthrough of a typical treatment timeline can help you sanity-check whatever schedule a clinic proposes for your specific stimulation protocol.
What Happens if the First Cycle Doesn’t Work?
Short answer: A cycle that does not succeed is clinical information, not a dead end — and it is also where unproven “add-ons” are most often sold to an anxious patient.
ESHRE’s 2023 good-practice recommendations reviewed dozens of supplementary tests, treatments, and procedures marketed as add-ons in reproductive medicine — additional to standard care, usually at extra cost — and found that the overwhelming majority are supported only by low-quality evidence, professional experience, or consensus, not high-quality trial data (ESHRE, Good Practice Recommendations on Add-ons in Reproductive Medicine, 2023). That does not make every add-on useless — some genuinely make sense for a specific case — but it does mean a clinic offering one after a failed cycle should be able to tell you why it applies to your case, not hand it over as a routine upsell. A structured review of what to check after a failed cycle, including your right to your own embryology records, covers this in more detail.
Clinical Note
Short answer: the biggest number on a clinic’s homepage is rarely its most useful feature — ask what it actually measures, and be wary of any process efficient enough to skip reviewing your file first.
In my own practice, I tell patients this directly: “The largest number on a website is not the clinic’s most important feature. Ask first who that rate actually includes — which age group, your own eggs or not, PGT-tested embryos or not, pregnancy per transfer or live birth per patient who started treatment.” A polished website, patient testimonials, a fast-responding coordinator, or a bundled “guaranteed package” can all create a good first impression — none of it tells you anything about the embryology lab itself. What concerns me is when a standard package and a high success percentage are offered before anyone has reviewed the patient’s actual file in detail. If a 70% success rate is promised before your age, ovarian reserve, and prior attempts have even been reviewed, that is a marketing sentence, not a personalized medical estimate.
The question about the lab I wish patients asked more often is specific: for my age and patient group, what share of mature eggs collected actually fertilize, what share of fertilized embryos reach blastocyst stage, and how does the clinic routinely audit those numbers? Patients usually ask about the incubator brand, whether time-lapse imaging is used, or for photos of the lab — but equipment brand alone does not determine lab quality. The experience and continuity of the embryology team, temperature/pH/air-quality control, a documented quality-assurance system, fertilization and blastocyst-development rates, post-thaw embryo survival, and identity-verification procedures that prevent sample mix-ups matter far more. The most expensive incubator is not a guarantee of a good lab — what matters is the team running it, the system built around it, and whether results are tracked honestly.
The approach I consider premature is offering a broad “implantation package” after a single failed transfer — ERA and microbiome testing, NK-cell testing, intralipid or IVIG, corticosteroids, endometrial scratching, thrombophilia panels, sometimes an unindicated hysteroscopy. Some of these may be worth considering in specific clinical situations, but one failed transfer, on its own, does not establish an immune or implantation problem in the uterus. What I tell a patient in that situation: an embryo not implanting does not necessarily mean something is wrong with your uterus. Let’s first review the embryo’s development, the age-related chance of a chromosomal issue, the lab process, the transfer technique, and the treatment as a whole — labelling one failed attempt with a new diagnosis right away usually adds a new worry and a new bill, not new information.
My overall approach: a good clinic is not the one performing the most add-on procedures. It is the one that can tell the difference between when further investigation is warranted, when the protocol should change, and when the same correct treatment deserves one more honest attempt.
— Dr. Senai Aksoy
At a Glance: A Clinic-Evaluation Checklist
Short answer: These questions apply to any clinic, in any country — use them as a single checklist regardless of where you are considering treatment.
| Question to ask | What a clear answer looks like | Why it matters |
|---|---|---|
| What quality-management system does the lab follow? | A specific, documented system — not “modern equipment” | Predicts consistency, not just capability |
| Is the success rate per transfer or cumulative? | A stated calculation method, with the denominator | The two numbers can differ substantially |
| What does local law require for your situation? | Written confirmation, verified independently | Determines what is legally possible at all |
| What is excluded from the base cost estimate? | A written, itemized list | Prevents cost surprises mid-treatment |
| How is an add-on after a failed cycle justified? | A case-specific clinical reason | Distinguishes evidence-based care from upselling |
Frequently Asked Questions
Is a more expensive clinic always a safer choice?
No. Price reflects what is included in a quote and local cost structures, not laboratory quality. Ask about accreditation and reporting standards directly rather than using price as a proxy for safety.
Can I ask to see a clinic’s actual embryology lab protocols?
You can ask how the lab documents its quality-management system, identity-witnessing process, and embryo-grading criteria. A clinic does not need to disclose proprietary detail to answer these questions in general terms.
Why do two clinics quote different success rates for what looks like the same procedure?
The rates are often calculated differently — per embryo transfer versus cumulative across a full treatment plan, or in different age brackets. Ask each clinic to state its calculation method and the population it applies to.
Are all reproductive medicine “add-ons” a waste of money?
Not necessarily, but most lack high-quality trial evidence and are not appropriate for every patient. A recommendation should come with a case-specific reason, not be offered as routine.
What should I do if my first cycle abroad fails?
Request your complete medical file, including embryology reports, before deciding on a next step. A meaningful second opinion depends on reviewing what actually happened in the previous cycle, not repeating the same protocol from a blank page.
Sources
- European Society of Human Reproduction and Embryology (ESHRE) Special Interest Group Embryology. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod. 2016;31(4):685-6. https://doi.org/10.1093/humrep/dew016
- ESHRE Add-ons working group. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104. https://doi.org/10.1093/humrep/dead184
- Chambers GM, Dyer S, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014. Hum Reprod. 2021;36(11):2921-2934. https://doi.org/10.1093/humrep/deab198
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.